The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms
about
Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growthThe modulation of apoptosis by oncogenic virusesA Small Molecule Inhibitor Selectively Induces Apoptosis in Cells Transformed by High Risk Human Papilloma VirusesExpression of HPV16 E5 produces enlarged nuclei and polyploidy through endoreplication.Human papillomavirus 16 E5 induces bi-nucleated cell formation by cell-cell fusion.A role for HPV16 E5 in cervical carcinogenesis.A conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers.The E5 proteinsAccelerated degradation of FADD and procaspase 8 in cells expressing human papilloma virus 16 E6 impairs TRAIL-mediated apoptosis.Modulation of apoptosis by human papillomavirus (HPV) oncoproteins.Papillomavirus E5: the smallest oncoprotein with many functions.Molecular genetics of human cervical cancer: role of papillomavirus and the apoptotic cascade.Molecular mechanisms of human papillomavirus-induced carcinogenesis.Modulation of apoptotic pathways by human papillomaviruses (HPV): mechanisms and implications for therapy.Bap31 is a novel target of the human papillomavirus E5 protein.The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.Characterization of the plasma membrane localization and orientation of HPV16 E5 for cell-cell fusionTumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.Human papillomavirus early proteins and apoptosis.Human papillomavirus oncoproteins and apoptosis (Review).MicroRNAs in cervical cancer: evidences for a miRNA profile deregulated by HPV and its impact on radio-resistance.The role of ubiquitin and ubiquitin-like modification systems in papillomavirus biology.Signaling pathways in HPV-associated cancers and therapeutic implications.Emerging Roles for RIPK1 and RIPK3 in Pathogen-Induced Cell Death and Host Immunity.MicroRNA and gynecologic cancers.Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells.The E5 protein of the human papillomavirus type 16 down-regulates HLA-I surface expression in calnexin-expressing but not in calnexin-deficient cells.Tyrphostin AG 555 inhibits bovine papillomavirus transcription by changing the ratio between E2 transactivator/repressor function.Virus Infection and Death Receptor-Mediated Apoptosis.How Human Papillomavirus Replication and Immune Evasion Strategies Take Advantage of the Host DNA Damage Repair Machinery.Oncogenic spiral by infectious pathogens: Cooperation of multiple factors in cancer development.Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.Human papillomavirus E5 oncoprotein: function and potential target for antiviral therapeutics
P2860
Q24559793-8099597E-39A2-42AC-BE20-C14C051FE2DCQ26995410-B74746FD-C0F9-4DAD-8203-609D944335DCQ28550190-CB45B7B1-DD1B-4F46-8B76-5B12161CA1A8Q30430582-11E0E3F2-9B6C-448E-BA50-EC9DA5C614A0Q30486597-A1956703-BBAA-420E-8065-9E26048A97D9Q33766992-F4B0B0F7-81E6-4323-A7CB-47AA1D401F5FQ34121681-5459D93A-AEFC-4F59-A8F0-E848E6D0FE9CQ34754347-35E603D5-536A-4C48-9977-F72EC11D9A82Q35082804-9D541B19-F33C-40A6-B850-0D79AC8D506FQ35545566-9E229B08-0D62-4463-A878-A7A613DCA723Q35642759-549205D9-24E2-4922-BCE0-489DB398D2D1Q35902272-2A23022A-9529-4E4F-8F85-4BBF5E6C8A8DQ36303426-F7D965D1-A813-47C8-B29A-76D098265257Q36482809-42E6E0CF-8B68-4FF9-8F77-B84E844C284AQ36933987-A2CD3CD3-3A44-4743-A344-9F0F70EC3BDBQ37232535-A98AA259-828F-4378-860D-814AB29D01D9Q37366709-23AF43D8-79BD-4C46-BCA1-D7490E62D816Q37810431-CF640764-77A4-49ED-A217-0EE4FFFBB487Q38069444-2DA6F3FE-2309-4D54-8F24-2F91156E4DF6Q38172151-7D5DA7CC-6032-4109-B629-FC5FA5832AE7Q38212798-617FFF6F-CC2F-459A-96FC-25189E9753A4Q38254163-F231C8F3-E87B-46D7-B68D-814FFF66419BQ38370778-A1C5E800-D47B-4081-BDD2-633E6A281BBFQ38589407-F67B2F3C-A5B2-430D-B861-61FE3B8ACF77Q38813155-8B2D6E7B-7C6D-4178-84C3-72852B1C802FQ39762451-C0E6E545-BA27-4705-8C60-E29AAE617F24Q40059928-7469FB26-0042-4F38-9C9B-21781F539A28Q42603771-ECC93804-04DE-4365-9E0E-067AD7C31C35Q45325588-2093865D-AA12-4C3B-BC80-D3696832A53FQ47159047-2CE09E32-B85D-4C48-8492-1A5198133BACQ47578584-23649EE8-F30E-4B90-8304-1D3A88E542FBQ53275556-2541D545-F1EB-4758-AC3A-E2B0A07D8119Q58420548-CFF00A64-C156-4EAF-9138-9E6C9F8B2AFB
P2860
The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
The human papillomavirus type ...... cells by different mechanisms
@en
The human papillomavirus type ...... cells by different mechanisms.
@nl
type
label
The human papillomavirus type ...... cells by different mechanisms
@en
The human papillomavirus type ...... cells by different mechanisms.
@nl
prefLabel
The human papillomavirus type ...... cells by different mechanisms
@en
The human papillomavirus type ...... cells by different mechanisms.
@nl
P2860
P1433
P1476
The human papillomavirus type ...... cells by different mechanisms
@en
P2093
Angel Alonso
Kirsten Kabsch
P2860
P304
12162-12172
P356
10.1128/JVI.76.23.12162-12172.2002
P407
P577
2002-12-01T00:00:00Z